|
Life Sciences Ontario Member's Directory
|
|
| Location: |
Saint-Pacôme, Quebec |
| Industry Sector: |
Supplier & Engineering |
| Website: |
www.inno-3b.com |
| Contact: |
Andrew Matthews (Array)
1 514 3705575 |
| Description: |
Inno-3B provides fully scalable, controlled environment plant production systems for the food, pharma, nutraceutical, and biotech industries. The company's vertical farming technology uses automation and digitalization in a closed-loop environment, enabling the growth of fresh organic produce in an environmentally friendly and cost-effective way. |
|
| Location: |
Ottawa, Ontario |
| Industry Sector: |
Public / Non-Profit Organizations / Medical Facilities |
| Website: |
innovativemedicines.ca |
| Contact: |
Pamela Fralick (info@imc-mnc.ca)
1 613 2360455 |
| Description: |
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. They advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. |
|
| Location: |
Burlingame, California |
| Industry Sector: |
Professional Services and Consulting |
| Website: |
www.inva.com |
| Contact: |
Marianne Zhen (Investor.relations@inva.com)
1 650 2389600 |
| Description: |
Innoviva, Inc. is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. |
|
| Location: |
Toronto, Ontario |
| Industry Sector: |
Medical Technology |
| Website: |
www.interfacebiologics.com |
| Contact: |
Thomas P. Reeves (info@interfacebiologics.com)
1 416 6738170 |
| Description: |
Interface Biologics, Inc. develops transformative biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices by reducing thrombosis, inhibiting infection and providing programmable delivery of pharmaceuticals. The company's drug delivery platforms are Epidel® technology and Kinesyx® technology. |
|
|
|
